Unlock Savings and Product Insights for Your Pharmacy!
Owen Mumford: Vital Updates for Medicare Part D Formulary
On January 1st, CVS Caremark revised their formulary, limiting insulin syringe and non-safety pen needle coverage to BD and Novo products. Owen Mumford has a workaround. Their Unifine SafeControl pen needles are approved at Rx submission, with a profitability of around $25—far surpassing the on-formulary options. Check out our informative PDF to stay in the know and empower your members.
![](https://www.ipcrx.com/wp-content/uploads/2024/03/Owen-Mumford-Unifine-SafeControl-Pen-Needles.webp)